Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (7): 444-446.
Previous Articles Next Articles
ZHANG Yanli , CHEN Lu, GUI Yue
Received:2019-08-06
Revised:2019-08-06
Online:2019-07-20
Published:2019-08-06
CLC Number:
ZHANG Yanli , CHEN Lu, GUI Yue. One Case of Dysuria Induced by Chinese Medicine Dispensing Granules Containing Ephedra[J]. Chinese Journal of Pharmacovigilance, 2019, 16(7): 444-446.
| [1] 曹怀远. 麻黄素中毒致尿潴留2例报告[J]. 陕西新医药,1982,11(8):27. [2] 范先伟. 口服麻黄碱引起尿潴留3例[J].实用医学杂志,1989,5(1):49. [3] 张桂林,王一琳. 口服麻黄素及百喘朋致老年人尿潴留2例[J]. 中国民政医学杂志,1996,8(4):244. [4] 马艳秋. 麻黄碱过量致尿潴留1例的护理[J]. 齐鲁护理杂志,2001,7(9):649. [5] 朱摇玲,汪民海. 复方盐酸伪麻黄碱缓释胶囊致排尿困难2例[J]. 安徽医药,2011,15(5):628. [6] 国家药典委员会. 中华人民共和国药典:一部(2015年版)[S]. 北京:中国医药科技出版社,2015:320-321. [7] 余光青,冷伟. 浅谈麻黄在小儿遗尿症中的应用[J]. 现代中医药,2018,38(5):109-111. [8] 林祥启. 麻黄汤治疗小儿遗尿症 56 例[J].实用中医药杂志,2000,16(1):24-25. [9] 彭宪章. 用麻杏石甘汤加味治愈遗尿症[J].新医药学杂志,1977,(11):31-32. [10] 吴力群. 刘弼臣教授临床应用麻杏石甘汤的经验[J].中国中西医结合儿科学,2010,2(1):56-58. [11] 陈芳瑜. 麻黄治疗遗尿症 331例临床分析[J].海峡药学,2004,16(1):88-89. [12] 李国芳. 俞景茂教授治疗小儿遗尿症经验介绍[J].中医儿科杂志,2016,12(4):12-15. [13] 宋艳红,宋晓辉,郭玉香. 麻黄素与654-2治疗小儿神经性尿频54例[J]. 黑龙江医学,1998,22(6):32. [14] 国家药典委员会. 临床用药须知:中药饮片卷(2015年版)[S]. 北京:中国医药科技出版社,2017:77. [15] 阿部靖之著,郭恒岳摘译. 麻黄提取物对家兔尿道及膀胱平滑肌的影响以及对腹压性尿失禁的作用[J]. 国外医学中医中药分册,2005,27(3):173-174. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
